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Abstract: 
Background: Patients with cancer grapple with a confusing array of disease- and treatment-
related symptoms while trying to maintain functioning in usual roles and daily activities. 
Research is needed to sort out and identify symptom clusters as a basis for a rational approach to 
symptom management. 
Objective: The aim of this study was to test, through secondary analysis, a mediation hypothesis 
about the direct and indirect relationships between fatigue and depressive symptoms through a 
pathway involving functional status. 
Methods: Data from the experimental and control groups of a randomized clinical intervention 
trial for fatigue management, collected after the second chemotherapy treatment or during the 
last week of radiotherapy, were analyzed. The mediation pathway from fatigue to depressive 
symptoms through functional status was tested separately for groups receiving either an energy 
conservation intervention or a control intervention, equating for time and attention. 
Results: For the control group, the results indicate support for partial mediation. The previously 
significant relationship between fatigue and depressive symptoms was reduced after functional 
status was controlled, accounting for 43% of the total mediated effect. The mediation hypothesis 
was not supported in the energy conservation group, indicating that the intervention may have 
changed the role of functional status in mediating the effect of fatigue on depressive symptoms. 
Discussion: In the control group, when routine activities became more difficult because of 
fatigue, individuals had more depressive symptoms. The results suggest that functional status is 
an important factor to consider in symptom management for fatigue. An appropriate intervention 
for fatigue would have two targets: the fatigue and strategies to reduce the likelihood of impaired 
functioning that could result in elevated depressive symptoms. 
Keywords: depressive symptoms, fatigue, functional status, symptom clusters 
 
Article: 
Individuals undergoing cancer treatment grapple with a confusing array of disease- and 
treatment-related symptoms while trying to maintain functioning in usual roles and daily 
activities. However, most research has been used to evaluate strategies for the management of 
individual symptoms such as pain (Miaskowski, Dodd, West, et al., 2004), fatigue (Yates et al., 
2005), or depression (Barsevick, Sweeney, Haney, & Chung, 2002). Given the complexity of the 
symptom experience for individuals undergoing cancer treatment, research is needed to begin to 
sort out and identify symptom clusters as a basis for a rational approach to the management of 
multiple symptoms (Barsevick, Whitmer, Nail, Beck, & Dudley, 2006). 
 
Presented here is a secondary analysis of data from a randomized clinical trial (RCT) of a fatigue 
management intervention during cancer therapy (Barsevick et al., 2004). Two cancer symptoms 
(fatigue and depression) were examined as a symptom cluster to identify the mechanism by 
which these two symptoms could be related. Both a direct association between the symptoms and 
an indirect relationship through a mediation pathway involving functional status, an important 
outcome in symptom management, were proposed. It was also proposed that there would be 
differences in the mediation results for the experimental and control groups. 
 
Symptom Clusters 
The identification of symptom clusters in medicine is not new. Before the 20th century, the 
diagnosis of illness was based largely on the systematic observation of clusters of signs and 
symptoms. More recently, in oncology, there has been a call to examine symptom clusters as a 
way of making sense of the complex cancer symptom experience (Dodd, Janson, et al., 2001; 
Dodd, Miaskowski, & Paul, 2001). Although there is no accepted definition of symptom cluster, 
Dodd defined it as concurrent and related symptoms (Dodd, Miaskowski, & Paul, 2001). 
Miaskowski (2004) has suggested that relationships among symptoms within a cluster could 
include a common mechanism or etiology, shared variance, or the production of outcomes that 
differ from individual symptoms. In this presentation, the focus is on the mechanism by which 
two symptoms could have an influence on one another. 
 
Research examining symptom clusters reflects an empirical search for common elements among 
individual symptoms that can link them as members of a cluster. Numerous studies have been 
used to demonstrate shared variance between symptom pairs, which has been described as an 
indicator of symptom clustering (Miaskowski, Dodd, & Lee, 2004). Correlation studies have 
included fatigue-insomnia (Beck & Schwartz, 2000; Miaskowski & Lee, 1999), fatigue-
depression (Dodd, Miaskowski, et al., 2001; Loge, Abrahamsen, Ekeberg, & Kaasa, 2000; 
Miaskowski & Lee, 1999; Redeker, Lev, & Ruggiero, 2000), fatigue-pain (Beck & Schwartz; 
Dodd, Miaskowski, et al., 2001; Gaston-Johansson, Fall-Dickson, Bakos, & Kennedy, 1999), and 
pain-depression (Gaston-Johansson et al., 1999). 
 
More recently, investigations have explored the mechanisms by which symptoms could influence 
one another. The direct and indirect relationships among symptoms and other variables have 
been explored through the use of mediation analysis. As defined by Baron and Kenny (1986), a 
mediator is a variable that accounts for the relationship between two other variables. Beck, 
Dudley, and Barsevick (2005) showed that one symptom could influence another symptom 
through its effect on a third symptom. A partial mediation model demonstrated that pain 
influenced fatigue directly and indirectly through an effect on sleep. That is, people who were in 
pain had poorer sleep quality, resulting in higher levels of fatigue. This model suggested that 
interventions for managing pain and reducing fatigue must also consider the individual's sleep 
quality. 
 
Although symptom clusters have been described without a specific theoretical basis, the concept 
easily fits into a number of theories, including the Theory of Unpleasant Symptoms (Lenz, Pugh, 
Milligan, Gift, & Suppe, 1997). This theory is used to address potential associations between and 
among multiple symptoms by asserting that symptoms can be related in complex ways, including 
mediated pathways. Also asserted is that symptoms can influence and be influenced by outcomes 
such as functional status. 
 
Functional Status Outcomes Associated With Symptoms 
From the standpoint of oncology nursing, functional status is an important outcome that is 
influenced by symptoms and symptom management. Functional status refers to one's ability to 
engage in usual activities and perform usual roles (Leidy, 1994). The variance in functional 
status has been accounted for by a set of symptoms (Dodd, Miaskowski, et al., 2001; Gaston-
Johansson et al., 1999; Gift, Jablonski, Stommel, & Given, 2004). Given, Given, Azzouz, and 
Stommel (2001) demonstrated that the presence of specific symptoms had differential effects on 
functional status. Compared with individuals who had no pain, fatigue, or insomnia, those with 
one, two, or all three symptoms were incrementally less likely to be functioning well 6-8 weeks 
after the diagnosis of cancer. In an RCT of a nursing intervention for pain and fatigue 
management, the group who received the symptom intervention had lower symptom severity and 
improved physical and social functioning (Given et al., 2004; Given, Given, Azzouz, Kozachik, 
& Stommel, 2001). 
 
Functional status has been linked to the symptom cluster of pain and depression through a 
mediation pathway (Williamson & Schulz, 1995). In a sample of outpatients with cancer, using a 
longitudinal analysis, it was shown that increased pain over time resulted in restriction of 
activities (an indicator of functional status), which predicted increased depressive symptoms. 
The findings demonstrated that pain and depressive symptoms were related directly and 
indirectly through their association with functional status. The results suggested that it was not 
the degree of pain that affected emotional well-being but the degree of disability that 
accompanied it. Other symptoms, such as fatigue and depression, could be related indirectly 
through a similar pathway involving functional status. 
 
Fatigue and Depressive Symptoms as a Symptom Cluster 
Fatigue and depression have been documented often as concurrent, related symptoms in patients 
with cancer. Of a sample of 987 patients with lung cancer enrolled in three chemotherapy clinical 
trials, 33% had sufficient depressive symptoms for them to be classified as depressed (Hopwood 
& Stephens, 2000). Fatigue was documented as an independent predictor of depression and 
functional impairment. Newell, Sanson-Fisher, Girgis, and Ackland (1999) documented that 
depressive symptoms were a significant problem for 23% of the participants in a sample of 201 
oncology patients undergoing chemotherapy. Physical symptoms were associated with 
depressive symptoms in this sample, and fatigue was one of the most common symptoms 
reported. In 457 persons with Hodgkin's disease, 26% had fatigue for 6 months or longer; these 
were defined as fatigue cases (Loge et al., 2000). Fatigue correlated moderately with depressive 
symptoms (r = .41). Fatigue cases had higher levels of depressive symptoms than those not 
defined as cases. 
 
Fatigue, depressive symptoms, and functional status were chosen for this analysis for several 
reasons. First, fatigue was a primary outcome in the parent study, which was reported by 97% of 
the study participants during cancer treatment. Depression was also a highly prevalent symptom, 
which was reported by 65% of the participants. Functional status was a primary outcome in the 
parent study. Although the experimental intervention reduced fatigue, it did not have a direct 
effect on functional status. However, it is possible that fatigue and functional status were part of 
a more complex mediation pathway involving depressive symptoms, as suggested by Williamson 
and Schulz (1995) in their analysis of pain and functional status. Using data from an RCT, it is 
possible to examine the differences in the proposed pathway for the experimental and control 
groups. Therefore, it was proposed that functional status was a mediator between fatigue and 
depressive symptoms in the control group but not in the group who received the intervention. 
 
METHODS 
Design and Sample 
This study was a secondary analysis of data from an RCT of an energy conservation intervention 
for managing fatigue during cancer therapy (Barsevick et al., 2004). Individuals were included in 
the clinical trial if they were initiating at least three cycles of chemotherapy (CTX), 6 weeks of 
radiation therapy (RT), or concurrent treatment (CTX/RT) and any previous treatment was at 
least 1 month before current treatment. The sample of the RCT consisted of 396 individuals 
treated for breast, lung, colorectal, advanced prostate, gynecologic, or testicular cancer or 
lymphoma. Criteria for exclusion were the following: treatment with stem cell transplantation or 
biotherapy, overt evidence of a psychiatric disorder, or initiation of treatment of anemia or 
depression during the past 3 weeks. 
 
Data on all participants in the RCT were collected before treatment. For the CTX or CTX/RT 
groups, follow-up data were collected 48 hr after the second and third cycles of chemotherapy. 
For the RT group, follow-ups occurred during the last week of radiation and 4 weeks after the 
completion of radiation. These time points have been documented as times of high fatigue during 
cancer treatment (Berger, 1998; Schwartz et al., 2000). Study participants received either a 
semistructured intervention focused on energy conservation and activity management (ECAM; n 
= 200) or a control intervention consisting of information on a healthy diet (n = 196). 
 
The primary aim of the RCT was to test the effect of the energy conservation intervention on 
fatigue and functional status. In the clinical trial, it was demonstrated that the ECAM 
(experimental) group had significantly lower fatigue, but there was no difference between the 
ECAM group and the control group with regard to functional status. A secondary aim of the 
RCT was to examine the interrelationships among fatigue, other symptoms, and functional 
status. The study protocol of the parent study was approved by the institutional review board in 
accordance with federal regulations, and informed consent was obtained from all study 
participants. No additional approval or consent was required for the secondary analysis because 
the original consent form covered this aim of the RCT. 
 
In keeping with the secondary aim of the RCT, this secondary analysis was undertaken to 
examine the direct and indirect relationships between fatigue and depressive symptoms, 
including a mediation pathway involving functional status. Data from the first follow-up point 
(48 hr after the second round of chemotherapy or the last week of radiation) were used. Separate 
hypotheses were proposed for the experimental and control groups. The control group 
intervention was intended to equate for time and attention but was not expected to influence the 
relationships among fatigue intensity, functional status, and depressive symptoms. In the 
secondary analysis for the control group, it was proposed that fatigue would influence depressive 
symptoms through a relationship with functional status as described by Williamson and Schulz 
(1995). That is, as fatigue increased, functional status was expected to worsen, resulting in more 
depressive symptoms. Because the ECAM group learned skills designed to lessen the impact of 
fatigue on functioning, it was proposed that functional status in the context of higher fatigue 




The General Fatigue Scale, a seven-item scale, was designed for the RCT to capture fatigue 
impact at specific times, including fatigue today, most days, the past 48 hr, and in general (Meek, 
Nail, & Jones, 1997). Two additional items were used to address distress due to fatigue and its 
impact on daily activities. For the secondary analysis, a mean was computed for the five fatigue 
intensity items (Table 1). The distress and impact items were excluded from the analysis to avoid 
confounding with the mediator and outcome variables. Cronbach's [alpha] reliability for this 
sample was .95. Evidence of validity of this scale included sensitivity to change in activity levels 
(p < .001) and a factor analysis demonstrating a single factor (Meek et al., 1997). 
 
 
TABLE 1. Variables Selected for the RCT and Secondary Analysis 
 
Functional Status 
In the RCT, the Functional Performance Inventory (FPI; Leidy, 1994), a 65-item scale with six 
subscales, was used to measure impairment of functional status due to treatment. Many items on 
the subscales had responses of "not applicable" because they were not relevant to the 
participant's usual activities. The 21-item household activities subscale had the fewest items 
rated as not applicable; thus, it was chosen for the secondary analysis (Table 1). Ratings for 
items such as "grocery shopping" included "doing with no, some, or much difficulty" (scored as 
3, 2, and 1, respectively) and "don't do for health reasons" (scored as 0). An item analysis of the 
21 items revealed 3 items rated by most respondents as not applicable. These 3 items were 
eliminated from the analysis. The score for household activities was computed by averaging the 
values across the 18 remaining items. Higher scores reflected less impaired functioning. The 
reliability and validity of the FPI have been demonstrated (Larson, Kapella, Wirtz, Covey, & 
Berry, 1998; Leidy, 1999). The internal consistency reliability computed for this sample was 




The Short Form of the Profile of Mood States (POMS-SF; McNair, Lorr, & Droppleman, 1992) 
is a 30-item adjective checklist measuring the intensity of symptoms during the past week; there 
are six subscales. For this analysis, the five-item depressive symptom subscale was used (Table 
1). Numerous studies have established the validity and reliability of POMS-SF and the subscales 
in patients with cancer (Barsevick et al., 2002). Responses to the adjective checklist ranged from 
1, not at all, to 5, extremely. The internal consistency of the POMS depression subscale was 
high; Cronbach's [alpha] = .86. 
 
Data Analysis 
Hierarchical multiple regression analyses were conducted to test the mediating effect of 
functional status on the relationship between fatigue and depression. Functional status would 
serve as a mediator if it accounted for all or some of the relationship between fatigue and 
depressive symptoms. In testing for mediation, the procedure set forth by Baron and Kenny 
(1986) was followed. Mediation was inferred when the following criteria were met: (a) the direct 
relationship between the predictor (fatigue) and outcome variable (depressive symptoms) was 
significant; (b) the predictor was significantly related to the mediator (functional status); (c) the 
mediator was significantly related to the outcome variable; and (d) a previously significant direct 
relationship between the predictor and outcome variable was reduced in magnitude after the 
mediator was controlled. If the relationship between the predictor and outcome variable was no 
longer significant after controlling the mediator, the mediation effect would be considered 
complete; if the relationship remained but its significance was reduced, the mediation effect 
would be considered partial. The mediation pathway was evaluated using the Sobel (1982) test, 
used to test the hypothesis that the indirect pathway from fatigue to depressive symptoms 
through functional status is different from 0 (Dudley, Benuzillo, & Carrico, 2004). Separate 
regression analyses were conducted for each intervention condition (ECAM vs. control group; 
MacKinnon, 1994). For each group, fatigue scores were entered as predictors, depressive 




The experimental and control groups did not differ at baseline with regard to demographic (Table 
2) or clinical (Table 3) factors. The results of the mediation analysis for the control and 
experimental groups are provided in Table 4. For the control group, the results indicated that 
functional status after cancer therapy mediated the relationship between fatigue and depressive 
symptoms. A significant path from fatigue to depressive symptoms ([beta] = .34, p < .001), from 
fatigue to functional status ([beta] = -.45, p < .001), and from functional status to depressive 
symptoms ([beta] = -.41, p < .001) was demonstrated. Furthermore, the previously significant 
relationship between fatigue and depressive symptoms was reduced after functional status was 
controlled ([beta] = .19, p = .02), and results of the Sobel test indicated that this indirect effect 
was significant (t = 3.34, p < .001). The results support a partial mediation model in the control 
group, accounting for 43% of the total mediated effect. 
 
 
TABLE 2. Demographic Characteristics of the Sample (N = 295) 
 
 
TABLE 3. Clinical Characteristics of the Sample 
 
 
TABLE 4. Regression Coefficients for Mediation Analysis 
 
For the ECAM group, fatigue was associated with depressive symptoms ([beta] = .39, p < .001); 
fatigue was also related to functional status ([beta] = -.50, p < .001), and functional status was 
associated with depressive symptoms ([beta] = -.30, p < .001). However, controlling functional 
status did not significantly reduce the relationship between fatigue and depressive symptoms 
([beta] = .31, p = .001), and the Sobel test was not significant. Thus, the mediation model failed 
in the ECAM group because the condition of a change in the relationship between the mediator 
and the outcome was not met. 
 
Discussion 
In the control group, as predicted, the mediation hypothesis was supported. Higher fatigue in the 
context of poorer functioning was related to a higher level of depressive symptoms. When 
increased fatigue made routine household activities more difficult, depressive symptoms 
increased. This finding is in agreement with the results for the mediating role of functional status 
with regard to symptoms in another cancer sample (Williamson & Schulz, 1995). This result 
suggests that depressive symptoms were more likely to be elevated in individuals whose 
functional status was impaired by fatigue and who did not have the skills needed to minimize 
fatigue impact. 
 
The same associations were tested for the ECAM group, who had been taught a common-sense 
coping skill to conserve energy. In this group, the mediation hypothesis was not supported. 
Although the direct associations between fatigue and functional status, between fatigue and 
depressive symptoms, and between functional status and depressive symptoms were significant, 
controlling for functional status did not add to the explanation of the relationship between fatigue 
and depressive symptoms. Compared with the finding for the control group, this result suggests 
that the pathway from fatigue to depressive symptoms through functional status had been 
disrupted by the ECAM intervention. 
 
This mediation analysis allowed consideration not only of changes in individual outcomes due to 
an intervention but also of changes in the relationships between variables. The results of the 
secondary analysis suggest that functional status is an important factor to consider in symptom 
management for fatigue because of its relationship with depressive symptoms. Based on these 
findings, an appropriate intervention for fatigue would have two targets: the fatigue and 
functional status. Teaching energy conservation strategies to patients with cancer undergoing 
treatment seems to have provided the skills needed to reduce fatigue and changed the 
relationship between functional status and depressive symptoms. The intervention could have 
served to reinforce the normalcy of fatigue as an expected, temporary symptom caused by 
treatment such that individuals undergoing cancer treatment did not become discouraged or 
depressed when they were less able to function in their usual activities. It is also possible that it 
enabled individuals with fatigue to set priorities to ensure that valued or important activities were 
continued and less important activities were let go. 
 
Although these results are promising, it is important to note that this was a secondary analysis of 
cross-sectional data from one time point after the ECAM or control intervention (Clarke & 
Cossette, 2000). As in the parent study, there was sampling bias due to missing data in both the 
experimental and control groups, with individuals in poorer health less likely to provide 
complete data (Barsevick et al., 2004). Also, the results only demonstrate associations among the 
variables of interest; causal relationships cannot be assumed because the secondary analysis 
focused on only one time point. Research is needed to examine the mediation hypothesis 
prospectively in other samples receiving interventions for symptom management. 
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